Use of cell lines to produce active therapeutic proteins

Details for Australian Patent Application No. 2004280238 (hide)

Owner MultiCell Technologies, Inc.

Inventors Bush, Thomas S.; Faris, Ronald A.; Liu, Jin

Agent Griffith Hack

Pub. Number AU-A-2004280238

PCT Pub. Number WO2005/034876

Priority 60/510,509 10.10.03 US

Filing date 7 October 2004

Wipo publication date 21 April 2005

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/034876 Priority application(s): WO2005/034876

1 June 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Apr 2006

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280239-Refractory period tracking and arrhythmia detection

2004280237-Extra-systolic stimulation therapy delivery and sensing via different electrode sets